Predictive role of GSTs on the prognosis of breast cancer patients with neoadjuvant chemotherapy

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 10, 2012, Pages 5019-5022

  Bai, Yun Lu ^a   Zhou, Bing ^a   Jing, Xiao Yue ^a   Zhang, Bin ^a   Huo, Xiao Qing ^a   He, Chao MaJian Miao ^b  

^a XINXIANG MEDICAL UNIVERSITY   (China)

^b 309TH HOSPITAL OF PLA   (China)

Author keywords

Bbreast cancer; Chemotherapy; GSTM1; GSTP1; GSTT1

Indexed keywords

EID: 84874016829     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.10.5019     Document Type: Article

References (18)

1. Arun BK, Granville LA, Yin G, et al (2010). Glutathione-s-transferase-pi expression in early breast cancer: association with outcome and response to chemotherapy. Cancer Investigation, 28, 554-9.
2. Ateş NA, Tamer L, Ateş C, et al (2005). Glutathione S-transferase M1, T1, P1 genotypes and risk for development of colorectal cancer. Biochem Genet, 43, 149-63.
3. Bafaloukos D (2005). Neo-adjuvant therapy in breast cancer. Ann Oncol, 16, 174-81.
4. Bosh TM, Meijerman I, Beijnen JH, et al (2006). Genetic polymorphisms of drug-metabolizing enzymes and drug transporters in the chemotherapeutic treatment of cancer.
5. Franco RL, Schenka NG, Schenka AA, et al (2012). Glutathione S-transferase Pi expression in invasive breast cancer and its relation with the clinical outcome. J BUON, 17, 259-64.
6. Funke S, Timofeeva M, Risch A, et al (2010). Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy. Pharmacogenomics, 11, 33-41.
7. International Agency for Research on Cancer (2008). Globocan 2008: Stomach Cancer incidence, Mortality and Prevalence Worldwide in 2008. IARC. http://globocan.iarc.fr/factsheets/cancers/liver.asp.
8. Lourenço GJ, Lorand-Metze I, Delamain MT, et al (2010). Polymorphisms of glutathione S-transferase mu 1, theta 1, and pi 1 genes and prognosis in Hodgkin lymphoma. Leuk Lymphoma, 51, 2215-21.
9. Mishra A, Chandra R, Mehrotra PK, et al (2011). Glutathione S-transferase M1 and T1 polymorphism and response to neoadjuvant chemotherapy (CAF) in breast cancer patients. Surg Today, 41, 471-6.
10. Mossallam GI, Abdel Hamid TM, Samra MA (2006). Glutathione S-transferase GSTM1 and GSTT1 polymorphisms in adult acute myeloid leukemia; its impact on toxicity and response to chemotherapy. J Egypt Natl Canc Inst, 18, 264-73.
11. Nagle CM, Chenevix-Trench G, Spurdle AB, et al (2007). The role of glutathione-S-transferase polymorphisms in ovarian cancer survival. Eur J Cancer, 43, 283-90.
12. Oliveira AL, Rodrigues FF, Santos RE, et al (2010). GSTT1, GSTM1, and GSTP1 polymorphisms and chemotherapy response in locally advanced breast cancer. Genet Mol Res, 9, 1045-53.
13. Ott K, Lordick F, Becker K, et al (2008). Glutathione-S-transferase P1, T1 and M1 genetic polymorphisms in neoadjuvant-treated locally advanced gastric cancer: GSTM1-present genotype is associated with better prognosis in completely resected patients. Int J Colorectal Dis, 23, 773-82.
14. Satta T, Isobe K, Yamauchi M, et al (1992). Expression of MDR1 and glutathione S transferase-pi genes and chemosensitivities in human gastrointestinal cancer. Cancer, 69, 941-6.
15. Wang W, Xia CQ, Liu N, et al (2008). Mechanistic study of potentiation of chemotherapy by a haloenol lactone derivative in vitro. Cancer Chemother Pharmacol, 62, 117-22.
16. Wang L, Jiang Z, Sui M, et al (2009). The potential biomarkers in predicting pathologic response of breast cancer to three different chemotherapy regimens: a case control study. BMC Cancer, 9, 226.
17. Whelan RD, Waring CJ, Wolf CR, et al (1992). Overexpression of P-glycoprotein and glutathione S-transferase pi in MCF-7 cells selected for vincristine resistance in vitro. Int J Cancer, 52, 241-6.
18. Zheng J, Wurz GT, Cadman TB, et al (1997). Haloenol lactone: a new synergist of chemotherapy in vitro. Biochem Biophys Res Commun, 241, 13-7.